HROW Q3 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$72M+45.4% YoY

Gross Profit

$54M75.3% margin

Operating Income

$15M20.6% margin

Net Income

$1M1.4% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$363M

Total Liabilities

$316M

Stockholders' Equity

$47M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$49M	+45.4%
Gross Profit	$54M	$37M	+44.8%
Operating Income	$15M	$1M	+1016.4%
Net Income	$1M	-$4M	+124.2%